TOI continues investment into Southern California clinical presence
CULVER CITY, Calif., March 16, 2022 — The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, expanded its footprint further into Southern California with the opening of its newest clinic in Culver City on March 7, 2022. The brand-new clinic offers comprehensive medical oncology services and is part of TOI’s investment in expanding access to quality and affordable oncology care for patients across the country.
In addition to opening its newest Culver City location, TOI recently expanded its Riverside clinic on March 14, 2022. The location added several exam rooms and tripled the size of the infusion space to ensure that TOI can continue to deliver leading cancer care solutions to the growing patient population of the Inland Empire.
“We’re pleased to be able to open two state-of-the-art clinics this month in Southern California, both of which offer patients enhanced access to high-quality oncology care,” said Dr. Daniel Virnich, President of TOI. “Our patients and clinicians will benefit greatly from the investments TOI has made into bringing our leading clinical trials program, outpatient transfusions, and other cutting-edge programs to the communities that we serve.”
About The Oncology Institute
Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.6 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced healthcare organizations. With 80+ employed clinicians and more than 600 teammates in more than 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
